• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Otologic and laryngologic manifestations of mucopolysaccharidoses after bone marrow transplantation.

作者信息

Papsin B C, Vellodi A, Bailey C M, Ratcliffe P C, Leighton S E

机构信息

Department of Otolaryngology, Great Ormond Street Hospital for Children, Toronto, Ontario, Canada.

出版信息

Otolaryngol Head Neck Surg. 1998 Jan;118(1):30-6. doi: 10.1016/S0194-5998(98)70371-7.

DOI:10.1016/S0194-5998(98)70371-7
PMID:9450825
Abstract

INTRODUCTION

Children with mucopolysaccharidosis have significant functional impairment of a number of systems because of deposition of glycosaminoglycans. The otolaryngologic system is affected, resulting in conductive and sensorineural hearing loss and voice abnormality.

METHOD

Eleven children who had undergone bone marrow transplantation had their hearing and voices assessed. Unmatched data from patients who had not undergone transplantation were collected for nonstatistical comparison.

RESULTS

The hearing loss in children who had undergone bone marrow transplantation was variable but on average was less severe than in the younger children who had not undergone transplantation. The incidence of otitis media with effusion was diminished in the transplanted group. Approximately half had normal voices.

DISCUSSION

Diminution of the progression of hearing loss and voice abnormality probably occurs in patients after treatment by bone marrow transplantation.

摘要

相似文献

1
Otologic and laryngologic manifestations of mucopolysaccharidoses after bone marrow transplantation.
Otolaryngol Head Neck Surg. 1998 Jan;118(1):30-6. doi: 10.1016/S0194-5998(98)70371-7.
2
[Hearing loss and airway problems in children with mucopolysaccharidoses].[黏多糖贮积症患儿的听力损失和气道问题]
Acta Otorrinolaringol Esp. 2011 Nov-Dec;62(6):411-7. doi: 10.1016/j.otorri.2011.05.003. Epub 2011 Jul 14.
3
Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.61例黏多糖贮积症患者的耳鼻咽喉科表现
Int J Pediatr Otorhinolaryngol. 2020 Aug;135:110137. doi: 10.1016/j.ijporl.2020.110137. Epub 2020 May 27.
4
A study of speech, language, hearing, and dentition in children with cleft lip only.单纯唇裂患儿的言语、语言、听力及牙列研究。
Cleft Palate Craniofac J. 2008 Sep;45(5):485-94. doi: 10.1597/06-207.1. Epub 2008 Jan 2.
5
Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway.黏多糖贮积症:耳鼻喉科检查结果、阻塞性睡眠呼吸暂停以及上气道淋巴组织中糖胺聚糖的蓄积
Int J Pediatr Otorhinolaryngol. 2014 Jun;78(6):944-9. doi: 10.1016/j.ijporl.2014.03.021. Epub 2014 Mar 27.
6
The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review.黏多糖贮积症的耳鼻喉科问题管理:一项回顾性研究。
J Otolaryngol. 1991 Jun;20(3):177-83.
7
Improvements in sensorineural hearing loss after cord blood transplant in patients with mucopolysaccharidosis.黏多糖贮积症患者脐血移植后感觉神经性听力损失的改善情况。
Arch Otolaryngol Head Neck Surg. 2012 Nov;138(11):1071-6. doi: 10.1001/jamaoto.2013.597.
8
The otologic manifestations of mucopolysaccharidoses.黏多糖贮积症的耳科表现。
Am J Otol. 1980 Oct;2(2):65-9.
9
Audiological profile in Apert syndrome.Apert综合征的听力学特征
Arch Dis Child. 2005 Jun;90(6):592-3. doi: 10.1136/adc.2004.067298.
10
Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation.黏多糖贮积症的心脏受累:异基因骨髓移植的影响
Arch Dis Child. 1995 Sep;73(3):259-60. doi: 10.1136/adc.73.3.259.

引用本文的文献

1
Hearing loss in patients with Morquio A syndrome: A scoping review.莫尔基奥A综合征患者的听力损失:一项范围综述。
Medicine (Baltimore). 2025 Jan 10;104(2):e41128. doi: 10.1097/MD.0000000000041128.
2
Hearing Loss in Mucopolysaccharidosis.黏多糖贮积症中的听力损失
Int Arch Otorhinolaryngol. 2021 Jul;25(3):e386-e391. doi: 10.1055/s-0040-1712107. Epub 2020 Sep 24.
3
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.黏多糖贮积症 I 型:当前的治疗方法、局限性和改进的前景。
Biomolecules. 2021 Jan 29;11(2):189. doi: 10.3390/biom11020189.
4
Hearing loss in patients with mucopolysaccharidoses-1 and -6 after hematopoietic cell transplantation: A longitudinal analysis.黏多糖贮积症 1 型和 6 型患者造血细胞移植后听力损失:一项纵向分析。
J Inherit Metab Dis. 2020 Nov;43(6):1279-1287. doi: 10.1002/jimd.12277. Epub 2020 Jul 9.
5
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.MPS VI 管理建议:基于系统证据和共识的指南。
Orphanet J Rare Dis. 2019 May 29;14(1):118. doi: 10.1186/s13023-019-1080-y.
6
Audiometric evaluation in individuals with mucopolysaccharidosis.黏多糖贮积症患者的听力测定评估
Clinics (Sao Paulo). 2018 Dec 3;73:e523. doi: 10.6061/clinics/2018/e523.
7
Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7 years follow-up.重度黏多糖贮积症II型患者的早期造血干细胞移植:7年随访
Mol Genet Metab Rep. 2017 Jun 8;12:62-68. doi: 10.1016/j.ymgmr.2017.05.010. eCollection 2017 Sep.
8
Mucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children.黏多糖贮积症I型;父母对疾病对其子女生活质量影响的看法。
Orphanet J Rare Dis. 2016 Jul 12;11(1):96. doi: 10.1186/s13023-016-0478-z.
9
The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis.拉罗尼酶治疗对黏多糖贮积症患者耳鼻喉科表现的影响。
Braz J Otorhinolaryngol. 2016 Sep-Oct;82(5):522-8. doi: 10.1016/j.bjorl.2015.09.006. Epub 2015 Dec 17.
10
Respiratory manifestations in patients with inherited metabolic diseases.遗传性代谢病患者的呼吸系统表现。
Eur Respir Rev. 2013 Dec;22(130):437-53. doi: 10.1183/09059180.00008012.